Before you join a UK peptide clinic — checklist

The 10 checks

1. Three registrations, one click each

A lawful UK peptide-prescribing clinic should be able to name:

• The prescriber (on the GMC, NMC, or GPhC register).
• The dispensing pharmacy (on the GPhC or PSNI register).
• For premises-based clinics in England, the premises CQC registration; HIS / HIW / RQIA in devolved nations.

You should be able to verify each yourself in under five minutes. If a clinic won’t name any of the three, that alone is a reason to walk away.

2. The clinical assessment is real

A real assessment covers history, medication, contraindications, mental health, and (for weight management) BMI and comorbidities. A 60-second tickbox form is not it. Ask: “Who reviews my intake form and how long does it take?”

3. The medicines are licensed UK brands

For GLP-1s the lawful answer is one of: Wegovy, Mounjaro, Saxenda, Ozempic (off-label requires documented justification), Rybelsus. “Compounded” mass-market GLP-1 supply is not the UK ‘specials’ framework. Other unlicensed peptides (BPC-157, CJC-1295, ipamorelin, etc.) being offered by a clinic should raise the regulatory question of what the clinic is taking clinical responsibility for.

4. Patient Information Leaflets are provided

Every UK licensed medicine ships with a PIL in English. If medicines arrive without a PIL, or with a PIL in a non-English language only, that’s a counterfeit-supply signal.

5. The dose schedule follows the licensed product

Wegovy titrates 0.25 → 2.4 mg over ~16 weeks. Mounjaro starts at 2.5 mg and steps to a tolerated maintenance. Anything else — “push to 3 mg Ozempic”, “double-dose your first injection” — is off-licence and uncommon. Ask why.

6. There’s a follow-up plan

Real clinics build in titration reviews, side-effect checks, and a route for adverse-event escalation. Ask: “What does follow-up look like and how often?”

7. There’s an out-of-hours escalation route

You should know who to contact if you develop severe symptoms — pancreatitis red flags, gallbladder pain, severe allergic reaction. The clinic isn’t expected to be a 24-hour emergency service, but they should make clear what to do (typically: NHS 111 / 999 + tell the prescriber after).

8. Side effects are communicated up front

Real clinics talk about nausea, gallbladder risk, pancreatitis red flags, pregnancy contraindication. Marketing-led clinics only mention the benefits. If side effects only appear in small print after you’ve paid, the priority isn’t your safety.

9. The pricing reflects the genuine market

Wildly under-priced GLP-1 supply is the consistent counterfeit signal. Don’t optimise for cheapest. See how to check a UK online pharmacy for pricing context.

10. The clinic doesn’t pressure you

Real clinical decisions can wait a day. Discount-codes-by-end-of-week, ‘limited stock’, ‘exclusive enrolment’ — all of these are sales pressure inappropriate for a medicine. Walk away.

Questions to ask in writing before signing up

• What is the full name of the prescriber who will assess me?
• What is the GMC / NMC / GPhC registration number?
• Which pharmacy will dispense the medicine?
• Are you CQC-registered? (If a premises-based clinic in England.)
• Which licensed medicine will I be prescribed?
• What is the typical dose schedule and how long is titration?
• What happens at the follow-up reviews?
• What do I do if I have a severe side effect at 2am?
• What is the policy if I want to stop the medicine?
• What is the refund / cancellation policy?

A clinic that won’t answer these in writing isn’t a clinic you want to use.

If a clinic fails the checks

• Don’t sign up. Don’t pay.
• Consider reporting marketing patterns to ASA and unlicensed-supply patterns to MHRA. See peptide advertising rules.
• Look at the NHS pathway and lawful private alternatives. See NHS vs private GLP-1 access.